Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials

por Myers JS, Vold S, Zaman F, Williams JM, Hollander DA
Publicado 2014

PERSIST: Physician's Evaluation of Restasis® Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review

por Mah F, Milner M, Yiu S, Donnenfeld E, Conway TM, Hollander DA
Publicado 2012

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye

por Stonecipher KG, Torkildsen GL, Ousler III GW, Morris S, Villanueva L, Hollander DA
Publicado 2016

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)

por Blinder KJ, Dugel PU, Chen S, Jumper JM, Walt JG, Hollander DA, Scott LC
Publicado 2017

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

por Fechtner RD, Harasymowycz P, Nixon DR, Vold SD, Zaman F, Williams JM, Hollander DA
Publicado 2011

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors

por Chang-Lin J-E, Batoosingh AL, Hollander DA, Schiffman RM, Tang-Liu D D-S.
Publicado 2011

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

por Ciolino JB, McLaurin EB, Marsico NP, Ackerman SL, Williams JM, Villanueva L, Hollander DA
Publicado 2015

Cone photoreceptor macular function and recovery after photostress in early non-exudative age-related macular degeneration

por Rodriguez JD, Lane K, Hollander DA, Shapiro A, Saigal S, Hertsenberg AJ, Wallstrom G, Narayanan D, Angjeli E, Abelson MB
Publicado 2018